Dispute over Vix, and mixed fortunes for vol products

New Angles

Last month, an Illinois court approved a request from the Chicago Board Options Exchange (CBOE) to dismiss a case brought against it by the Chicago Mercantile Exchange (CME) over futures on Vix – the CBOE’s measure of implied volatility of S&P 500 equity index options. The CME had claimed that by listing the volatility products – the first of which launched in March – the CBOE had infringed upon the CME’s exclusive license agreement with Standard & Poor’s that covers futures contracts based

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: